ISSN 1612-3352

Editors in Chief

Prof. Dr. Claus F. Claussen, Neurootological Research Institute of the Research Society for Smell, Taste, Hearing and Equilibrium Disorders at Bad Kissingen (4-G-F). Bad Kissingen, Germany.
Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Production Managers

Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.


Associated Editors


The editors welcome authors to submit articles for publications in the ASN.

Read the Information for Authors.


Kurhausstraße 12
D-97688 Bad Kissingen
Germany
Telefon +49-971-6 4832
Fax +49- 971- 6 8637
Email asn@neurootology.org

 

Current trends of neurootological pharmacotherapy

Abstract

Major neurootological complaints, which mostly need drug treatment, are: giddiness,

dizziness, hearing loss and tinnitus. The neurootological differential diagnosis is the basis

for planning the mostly supportive treatment of vertigo patients. In planning the therapy, we

are utilizing a computerbased expert system CLAMEDEX for establishing the

neurootological diagnosis through history, ORL inspection, ENG, calorics, rotatory chair test,

cranio-corpo-graphy (CCG), optokinetics, psychophysical audiometry, acoustic brainstem

and late evoked potentials, visually evoked potentials etc.. On this knowledge base we are

designing an individually adapted case oriented drug therapy.

Nausea and vomitus are the important subjective complications of dysequilibrium states.

Therefore antivertiginous and antiemetic therapies have to be applied if necessary. Usually

the duration is of limited time.

Oher drugs being chosen for a supportive pharmaco therapy according to the functional

topodiagnostics of the lesions usually possess one or more of the following actions upon the

equilibrium regulating network:

1. increase of cerebral blood flow,

2. enhanced penetration through the blood brain barrier,

3. increase of neuronal metabolism and

4. stabilization of specific neurotransmitters.

The neurootological patients are treated and monitored by regular neurootometric follow up

investigations.

Login

Registration

If you are not already registered, please register here for free.

If you are registered but have forgotten your password (or you never had one), click here to recover your password.

Proceedings of

Authors

Archives

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |

(bi)gital»